Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mina Sooch
AddedMar 31, 2024
UpdatedMay 31, 2026
Mina Sooch

Mina Sooch

Co-Founder, Apjohn Ventures

CrunchbaseLinkedIn

Mina Sooch's Career

Apjohn Ventures
Apjohn Ventures

Kalamazoo, MI, US

Co-Founder
Ocuphire Pharma
Ocuphire Pharma

Farmington Hills, MI, US

Board Member· Board
Svelte Medical Systems
Svelte Medical Systems

New Providence, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mina Sooch's Career

Apjohn Ventures
Apjohn Ventures
Investment Firm72003Kalamazoo, MI, US
Co-Founder

Leadership at Apjohn Ventures

Donald ParfetDonald ParfetCo-Founder
Ocuphire Pharma
Ocuphire Pharma
Public$24.6M82018Farmington Hills, MI, US
Board Member· Board

Leadership at Ocuphire Pharma

Sean AinsworthSean AinsworthBoard Member
Cam GallagherCam GallagherBoard Member
Rick RodgersRick RodgersBoard Member
Alan MeyerAlan MeyerBoard Member
Susan BentonSusan BentonBoard Member
Dr James S J ManusoDr James S J ManusoBoard Member

Similar to Ocuphire Pharma

Ocumension TherapeuticsOcumension TherapeuticsShanghai, Shanghai, CNPharmaceuticals, Therapiesest. 2017Ocumension TherapeuticsShanghai, Shanghai, CN · est. 2017

Ocumension Therapeutics: A dedicated platform for developing and commercializing ophthalmic therapies.

Public · $200M175
OcuCure TherapeuticsOcuCure TherapeuticsRoanoke, VA, USEye Drops, Pharmaceuticalsest. 2005OcuCure TherapeuticsRoanoke, VA, US · est. 2005

OcuCure Therapeutics: Developing innovative eye drops for age-related and diabetic eye diseases since 2005.

Public · $3.3M8
EyePointEyePointWatertown, MA, USDrug Devicesest. 2008EyePointWatertown, MA, US · est. 2008

EyePoint Pharmaceuticals, a global biopharmaceutical firm, develops drug devices for chronic eye disorders.

Public · $653.8M144
Ocular TherapeutixOcular TherapeutixBedford, MA, USOphthalmic Therapiesest. 2006Ocular TherapeutixBedford, MA, US · est. 2006

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

Public · $386.5M274
Svelte Medical Systems
Svelte Medical Systems
Series A$128.4M302007New Providence, NJ, US
Board Member· Board

Leadership at Svelte Medical Systems

Richard DakersRichard DakersBoard Member
Bob FischellBob FischellBoard Member
Somu SubramaniamSomu SubramaniamBoard Member
Bob CroceBob CroceBoard Member
Jack DarbyJack DarbyCEO
Bob FlanaganBob FlanaganBoard Member

Similar to Svelte Medical Systems

NovostentNovostentMountain View, CA, USMedical Devices, Stentsest. 2003NovostentMountain View, CA, US · est. 2003

NovoStent Corp: Innovating stent technologies for vascular treatments across the US healthcare sector.

Pre-Seed · $14.4M6
East End MedicalEast End MedicalMiramar, FL, USMedical Devicesest. 2017East End MedicalMiramar, FL, US · est. 2017

East End Medical: Innovating catheter-based cardiac procedures with advanced medical devices.

Seed · $1.4M27
Dalent MedicalDalent MedicalMiami, FL, USMedical Devicesest. 2017Dalent MedicalMiami, FL, US · est. 2017

Dalent Medical: Innovating ENT care with the world's first universal Sinusleeve™ Balloon for better patient outcomes.

Seed · $2.5M30
Trireme MedicalTrireme MedicalPleasanton, CA, USCatheters, Medical Devices, Stentsest. 2005Trireme MedicalPleasanton, CA, US · est. 2005

TriReme Medical, Inc. globally provides advanced coronary and arterial disease treatment devices.

Public · $58.9M75

People Similar to Mina Sooch

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu